- Trials with a EudraCT protocol (917)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (3)
917 result(s) found for: Colorectal Cancer.
Displaying page 13 of 46.
| EudraCT Number: 2019-003770-85 | Sponsor Protocol Number: DKFZ-2019-007 | Start Date*: 2020-08-20 |
| Sponsor Name:German Cancer Research Center (DKFZ) | ||
| Full Title: Effect of low-dose acetylsalicylic acid on early detection of advanced colorectal neoplasms | ||
| Medical condition: Screening for advanced colorectal neoplasms. Male individuals aged 40 to 79 years scheduled for screening colonscopy and no use of acetylsalicylic acid (or other drugs with an effect on the blood ... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male | |
| Trial protocol: DE (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-005154-44 | Sponsor Protocol Number: OPERA | Start Date*: 2006-03-02 | |||||||||||
| Sponsor Name:Universitätsklinikum Hamburg-Eppendorf | |||||||||||||
| Full Title: OPERA: OXALIPLATIN AND CETUXIMAB IN FIRST-LINE TREATMENT OF mCRC Open, non-controlled, multicenter phase II study evaluating 5-FU/FA plus oxaliplatin (FOLFOX-4) plus cetuximab as first-line treatme... | |||||||||||||
| Medical condition: metastasized colorectal cancer | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) AT (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2020-002715-21 | Sponsor Protocol Number: AIO-KRK-0220 | Start Date*: 2021-10-22 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sponsor Name:AIO-Studien-gGmbH | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Full Title: Perioperative/Adjuvant atezolizumab in patients with MSI-high or MMR-deficient stage II high risk or stage III colorectal cancer ineligible for oxaliplatin-based chemotherapy– a Phase II study (ANT... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Medical condition: Patients with MSI-high or MMR-deficient stage III colorectal cancer who are ineligible for or who refuse oxaliplatin-based chemotherapy after R0 tumor resection (main study) or planned resection (s... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trial protocol: DE (Trial now transitioned) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EudraCT Number: 2014-000834-50 | Sponsor Protocol Number: MGN1703-C06 | Start Date*: 2014-07-09 | |||||||||||
| Sponsor Name:MOLOGEN AG | |||||||||||||
| Full Title: IMPALA-Trial: Evaluation of an immunomodulatory maintenance treatment in patients with metastatic colorectal cancer with tumor reduction during induction treatment - A phase III trial | |||||||||||||
| Medical condition: Metastatic colorectal cancer | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Prematurely Ended) DE (Completed) BE (Prematurely Ended) IT (Ongoing) EE (Prematurely Ended) AT (Prematurely Ended) ES (Prematurely Ended) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2014-001855-22 | Sponsor Protocol Number: M14AFS | Start Date*: 2015-01-14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sponsor Name:Netherlands Cancer Institute- Antoni van Leeuwenhoek Hospital | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Full Title: Phase I/II study with the combination of afatinib and selumetinib in advanced KRAS mutant positive and PIK3CA wildtype non-small cell lung cancer and colorectal cancer | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Medical condition: Patients with histological or cytological proof of advanced KRAS mutant and PIK3CA wildtype non small cell lung cancer (NSCLC) and colorectal cancer (CRC). In part B: for which first-line treatment... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trial protocol: NL (Completed) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EudraCT Number: 2007-002913-38 | Sponsor Protocol Number: DIPROCOL-0707 | Start Date*: 2007-07-20 | ||||||||||||||||
| Sponsor Name:Centre Oscar Lambret | ||||||||||||||||||
| Full Title: Essai de phase II multicentrique sur le traitement préventif de la folliculite induite par les anti-EGFR chez des patients atteints de cancer colorectal métastatique sous Cetuximab ou atteints de c... | ||||||||||||||||||
| Medical condition: Cancer colorectal métastatique exprimant l’EGFR et cancer bronchique non à petites cellules localement avancé ou métastatique, exprimant l’EGFR | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: FR (Ongoing) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2020-000451-12 | Sponsor Protocol Number: BNT122-01 | Start Date*: 2021-03-19 | |||||||||||||||||||||
| Sponsor Name:BioNTech SE | |||||||||||||||||||||||
| Full Title: A multi-site, open-label, Phase II, randomized, controlled trial to compare the efficacy of RO7198457 versus watchful waiting in resected, Stage II (high risk) and Stage III colorectal cancer patie... | |||||||||||||||||||||||
| Medical condition: Colorectal cancer (Stage II [high risk] and Stage III) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: DE (Trial now transitioned) BE (Trial now transitioned) | |||||||||||||||||||||||
| Trial results: (No results available) | |||||||||||||||||||||||
| EudraCT Number: 2005-003440-66 | Sponsor Protocol Number: D8480C00013 | Start Date*: 2006-09-11 | |||||||||||
| Sponsor Name:AstraZeneca AB | |||||||||||||
| Full Title: A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of AZD2171 in Combination with 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizuma... | |||||||||||||
| Medical condition: This is a Phase II / III trial in Patients with Previously Untreated Metastatic Colorectal Cancer. | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: BE (Completed) AT (Completed) CZ (Completed) DE (Completed) SK (Completed) HU (Completed) IT (Completed) GB (Completed) FI (Completed) LV (Completed) MT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2008-005074-12 | Sponsor Protocol Number: 20070411 | Start Date*: 2009-03-04 | |||||||||||||||||||||
| Sponsor Name:Amgen Inc | |||||||||||||||||||||||
| Full Title: A Phase 1b/2 Open Label, Dose Escalation Study of AMG 655 in Combination with AMG 479 in Subjects with Advanced, Refractory Solid Tumors. -------------------------------------------------------- Es... | |||||||||||||||||||||||
| Medical condition: Part 1: Advanced, treatment-refractory solid tumors Part 2: Advanced non-small cell lung cancer (NSCLC), colorectal cancer (CRC), pancreatic cancer, ovarian cancer, or sarcoma. --------------------... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: ES (Completed) | |||||||||||||||||||||||
| Trial results: View results | |||||||||||||||||||||||
| EudraCT Number: 2020-002533-14 | Sponsor Protocol Number: REVERT | Start Date*: 2021-02-15 | ||||||||||||||||
| Sponsor Name:DIP. MEDICINA DEI SISTEMI UNIVERSITà DEGLI STUDI DI ROMA TOR VERGATA | ||||||||||||||||||
| Full Title: REVERT – taRgeted thErapy for adVanced colorEctal canceR paTients. | ||||||||||||||||||
| Medical condition: unresectable metastatic colorectal cancer (mCRC) | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: IT (Prematurely Ended) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2010-023580-18 | Sponsor Protocol Number: 62202-529 | Start Date*: 2011-05-04 | |||||||||||
| Sponsor Name:Merck, S.L | |||||||||||||
| Full Title: Ensayo clínico fase II, de cetuximab en cáncer colorrectal metastático refractario con K-RAS mutado y genotipos FcyRII/IIIa favorables Phase II clinical study of cetuximab in refractory colorectal ... | |||||||||||||
| Medical condition: Sujetos con CCRm, estadio IV, refractario al tratamiento estándar, que presentan el gen K-RAS mutado y genotipos FcγRII/IIIa favorables, con genotipos FcγRIIa-131H/H y/o FcγRIIIa 158V/V | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2007-000233-18 | Sponsor Protocol Number: AIO KRK 0205 | Start Date*: 2008-04-09 | |||||||||||
| Sponsor Name:Universität zu Köln | |||||||||||||
| Full Title: Phase I/II Studie zum Einsatz von Capecitabin und Oxaliplatin (XELOX) in Kombination mit Bevacizumab und Imatinib in der Erstlinientherapie von Patienten mit fortgeschrittenem kolorektalem Karzinom | |||||||||||||
| Medical condition: fortgeschrittenes kolorektalen Karzinom mit inoperablen Metastasen | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2020-003795-40 | Sponsor Protocol Number: GEMCAD-1802 | Start Date*: 2020-12-01 | |||||||||||
| Sponsor Name:Grupo Español Multidisciplinar en Cáncer Digestivo (GEMCAD) | |||||||||||||
| Full Title: Randomized and multicentre Phase II study of FOLFOX6m + monoclonal Ab (anti-EGFR or bevacizumab) alone or in combination with hepatic chemoembolization (Lifepearls-Irinotecan) in patients with colo... | |||||||||||||
| Medical condition: Colorectal cancer patients with metastatic disease limited to the liver with poor prognostic criteria. | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2016-000621-39 | Sponsor Protocol Number: Sym004-11 | Start Date*: 2016-11-25 | |||||||||||
| Sponsor Name:Symphogen A/S | |||||||||||||
| Full Title: An Open-label, Multicenter, Phase 2 Trial Investigating Sym004 in Patients with Metastatic Colorectal Cancer and Acquired Resistance to Anti-EGFR Monoclonal Antibodies and Documented Mutation of Ex... | |||||||||||||
| Medical condition: Metastatic Colorectal Cancer and Acquired Resistance to Anti-EGFR Monoclonal Antibodies and Documented Mutation of Extra Cellular Doman of EGFR | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Completed) IT (Prematurely Ended) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2022-002214-17 | Sponsor Protocol Number: NL78220.029.21 | Start Date*: 2023-04-24 | ||||||||||||||||
| Sponsor Name:Amsterdam University Medical Centers | ||||||||||||||||||
| Full Title: COLLISION RELAPSE trial - Recurrent colorectal liver metastases: repeat local treatment +/- neoadjuvantsystemic therapy - a phase III prospective randomized controlled trial | ||||||||||||||||||
| Medical condition: Recurrent colorectal liver metastases | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: NL (Trial now transitioned) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2006-000044-71 | Sponsor Protocol Number: V3Aug2008 | Start Date*: 2006-10-02 |
| Sponsor Name:University Hospitals of Leicester NHS Trust Research & Development Department | ||
| Full Title: Randomised controlled trial of the effects of fish oil emulsion in total parenteral nutrition upon tumour vascularity in patients with hepatic colorectal metastases | ||
| Medical condition: Potentially resectable hepatic (liver) metastases from colorectal (bowel) cancer. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2007-002053-24 | Sponsor Protocol Number: 07_DOG03_133 | Start Date*: 2007-10-26 |
| Sponsor Name:The Christie NHS Foundation Trust | ||
| Full Title: A phase II study evaluating the use of concurrent cetuximab, irinotecan, oxaliplatin and UFT in the first line treatment of patients with metastatic colorectal cancer | ||
| Medical condition: Advanced, inoperable or metastatic colorectal cancer. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2013-000653-42 | Sponsor Protocol Number: OC-AP-ICG-IV | Start Date*: 2013-03-20 |
| Sponsor Name:Jules Bordet Institute | ||
| Full Title: Feasibility study of the (intravenously injected) ICG imaging of tumoral implants in patients with peritoneal carcinomatosis from colorectal cancer | ||
| Medical condition: Peritoneal carcinomatosis from colon Cancer. | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2011-005547-27 | Sponsor Protocol Number: GO28074 | Start Date*: 2012-10-24 | |||||||||||||||||||||
| Sponsor Name:Genentech, Inc. | |||||||||||||||||||||||
| Full Title: A PHASE II, MULTICENTER, OPEN-LABEL, RANDOMIZED STUDY EVALUATING THE EFFICACY AND SAFETY OF FOLFIRI + MEHD7945A VERSUS FOLFIRI + CETUXIMAB IN SECOND LINE IN PATIENTS WITH KRAS WILD-TYPE METASTATIC ... | |||||||||||||||||||||||
| Medical condition: Colorectal cancer that does not carry mutation in the KRAS gene | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: DE (Prematurely Ended) GB (Prematurely Ended) BE (Completed) ES (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||||||||||||
| Trial results: View results | |||||||||||||||||||||||
| EudraCT Number: 2019-004624-38 | Sponsor Protocol Number: BOT112-02 | Start Date*: 2020-06-11 | ||||||||||||||||
| Sponsor Name:Highlight Therapeutics, S.L | ||||||||||||||||||
| Full Title: Phase IIa open-label clinical study of intratumoural administration of BO-112 in combination with pembrolizumab in subjects with liver metastasis from colorectal cancer or gastric/gastro-oesophagea... | ||||||||||||||||||
| Medical condition: Colorectal cancer or gastric/gastro-oesophageal junction cancer with liver metastasis | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: BE (Prematurely Ended) ES (Prematurely Ended) IT (Prematurely Ended) DE (Prematurely Ended) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
